In This Interview, The Premier Of Ontario Discusses The Province’s Significant Commitment To Advancing And Sharing The Extraordinary Benefits Of Nuclear Energy With Citizens Around The World, Both In Industrial And Medical Fields. A TRUE VISIONARY AND A LEADER WHO TURNS IDEAS INTO REALITY. Ontario announced an investment of $40 million dollars to help companies […]
Read articleRaymond Taillefer MD, FRCP, ABNM Director of Nuclear Medicine, Hôpital du Haut Richelieu, St-Jean-sur-Richelieu, Québec, Canada Pulmonary embolism (PE) is a blockage in one or more of the pulmonary arteries of the lungs. Most of the time, PE results from blood clots travelling to the lungs and originating from deep veins in the legs (deep […]
Read articleGERO-THERANOSTICS Nuclear Medicine & Theranostics As the 21st century dawned, nuclear medicine faced a bleak outlook. The advent of clinical ultrasonography, computerized tomography, and magnetic resonance seemed to overshadow our field’s relevance, while a dearth of investments in novel radiopharmaceuticals and relying on decades old Anger physics cast a shadow over its future. Yet, through […]
Read article
Positron Emission Tomography (PET) is a cutting edge, non-invasive, diagnostic imaging technique which allows the measurement of biochemical processes or the expression of cellular receptors by the use of positron-emitting radioactive tracers. The imaging tracers most often contain atoms naturally found in organic molecules, but in the form of radioactive analogues of Oxygen (15O), Nitrogen […]
Read article
Prostate specific membrane antigen (PSMA) is a membrane glycoprotein with enzymatic activity (as explained in vol.1 no.2. by Jean-Luc Urbain). It is highly expressed in high-risk prostate cancer and therefore PSMA could be a basis for theragnostics. 177Lu-PSMA radioligand therapy is mainly used for patients with end-stage prostate cancer, but it can be used earlier. […]
Read article
INTRODUCTION: In the second issue of our magazine we described the therapeutic use of Iodine, the first true Theranostics compound available. In this edition of our magazine we will put the emphasis on the most recent developments in the utilization of medical isotopes for therapy of cancers. The modern landmark for Theranostic nuclear medicine […]
Read article
Dr. Jun Hatazawa, M.D., Ph.D., President of the AOFNMB, Japan BASIS OF NUCLEAR BRAIN IMAGING Brain is an organ by which we can perceive, exercise, learn, remember, think, behave and imagine among other tasks. To fulfill its functions, the brain exclusively metabolizes glucose to produce energy in the form of adenosine triphosphate (ATP) by oxidative […]
Read article
Dr. Kamel Hasan, Olfat, MBChB, FRCR, FRCPC Nuclear Medicine and Molecular Imaging Physician Hamilton Health Sciences and St. Joseph’s Healthcare McMaster University Ontario, Canada INTRODUCTION Over the past 30 years, there have been colossal advances in the way we have lived life through the development and innovation of scientists worldwide. From the creation of the […]
Read articleChristopher O’Brien MDCM; FRCPC Medical Director, Nuclear Medicine Brantford General Hospital Ontario, Canada FRACTURES A DIFFERENT APPROACH: THE ROLE OF EARLY BONE SCANNING The three-phase bone scan is a very sensitive technique used in the detection of fractures of any cause. The sensitivity can be further increased through the use of SPECT and the specificity can be […]
Read article
James McBrayer CEO, Cyclopharm Ltd www.cyclopharm.com You have been actively involved in the field of nuclear medicine for quite a while. Looking back at your career, what are the most significant changes that you have witnessed in the field over the past 10 years? I have witnessed a great deal of change since starting in […]
Read article
